The announcement of a significant reduction in operating expenses is a strong indicator of ReShape Lifesciences' strategic planning and operational efficiency improvements. This move is likely to be viewed positively by investors as it directly impacts the company's bottom line and its path to profitability. The emphasis on cost reduction while reaffirming the commitment to profitability suggests a proactive approach to financial management, which could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.